🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Shout out to my awesome co-resident and soon to be chief Zachary Mayo for receiving an Early Career Oncologist Award for his sarcoma work!!! Keep up the great work! Samuel Chao Shauna Campbell, DO John Suh Jake Scott Chirag Shah Rahul Tendulkar, MD @Wafa_asha89 Sarah Kilic, MD

I am truly humbled by my amazing co-residents, who teach me so much about oncology and about life every day. My senior resident Timothy Smile is not only the most skilled and compassionate doctor, but an expert pianist. Best lunch break ever listening in CCF pavilion. #radonc

Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study ascopubs.org/doi/abs/10.120…

Congratulations to Sarah Kilic, MD PGY4 #radonc Cleveland Clinic for being awarded a ASCO Conquer Cancer, the ASCO Foundation merit award for her project evaluating breast cancer screening in homeless women! So proud of the work you are doing 🤗 John Suh Jame Abraham, MD, FACP Rahul Tendulkar, MD Chirag Shah

I am so grateful to have received a Conquer Cancer, the ASCO Foundation ASCO Merit Award for our work investigating breast cancer screening in patients experiencing homelessness. Thankful for my mentors and collaborators John Suh Chirag Shah Jeremy Weleff Cleveland Clinic MD #radonc

I put together a few high-yield slides for #RadOnc oral boards RT-friendly regimens for HL and NHL. 📌 For HL, there is a focus on GHSG staging for a simplified decision tree. 📌 Goal: Not comprehensive. Comments and feedback are welcomed! Enjoy 😃 bit.ly/RadOncHemeOral…

Oral boards for #RadOnc are approaching. Here is advice to anyone taking the exam. ARRO ASTRO ACRO - American College of Radiation Oncology ACROresident

Big welcome to our new PGY2s @jkocsis11 Erik Davies Ani Bommireddy and fellow Sami Koro to the Cleveland Clinic #radonc family. ☢️ Our new program director Sudha Amarnath MD and the rest of the team are excited to work with you! John Suh Rahul Tendulkar, MD

After a decade plus of hard work delighted to say that NRG Oncology BN-012 randomized phase III trial of pre-op vs post-op SRS for resected brain metastases is slated to open this week! #radonc and #Neurosurgery let’s enroll and answer this important #timing question.

What is the ideal management of biochemically (PSA) recurrent prostate cancer after prostatectomy? Here are case scenarios that place treatment strategies in perspective. This will be a thread of subthreads. 🧵 #PCSM #RadOnc

Excited to see this book published! Thank you for the collaboration Dr Rembielak Dr Tagliaferri Sandro Porceddu Jimmy Broughman Zachary Mayo Cleveland Clinic MD Peter Mac Radiation Oncology The Christie NHS

🙌INTERLACE trial - induction chemotherapy + chemoXRT vs chemoXRT alone in locally advanced #CervicalCancer ✅🤩Compliance was good Induction yielded increased Progression free survival: HR 0.65 (p-0.013) Overall survival: HR 0.61 (p=0.04) #gyncsm #radonc #ESMO2023

🚨🚨🚨 Rectal Cancer Tweetorial!! Rectal cancer is a highly heterogeneous disease with rapid evolution in practice. Let's review current data to generate a pragmatic, patient-centric, approach to management! #GI24 #GIonc #RadOnc Thank you ASCO for the opportunity!🙏🏽 1/

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… Glenn J. Hanna, M.D. ASDS Members ASCO American Society of Nephrology American Society of Transplantation (AST) #skin #cancer

PACIFIC regimen improves OS for LA-NSCLC and now LS-SCLC. #radonc QuadShot News

RT and SBRT are highly effective for localized prostate cancer Nevertheless, there are few pts with intraprostatic failure Prospective study of salvage reirradiation ascopubs.org/doi/10.1200/JC… 5-year local recurrence-free survival: 93% Durable grade 3 genitourinary toxicity: 5%

Diary of a Rad Onc Resident. Just came across this tongue-in-cheek 'typical' day in #radonc ! Made me actually laugh out loud! Found it on Reddit.

Stereotactic ablative radiotherapy appeared to have excellent local control with minimal toxic effects in this large patient group with gynecologic cancers, and certain patients may achieve durable distant control and OS as well. ja.ma/4c3CgDZ

SBRT for Gynecological Oligometastatic and Oligoprogessive Tumors - retrospective, 215 pts, 5 institutions - most frequently endometrium & ovary ca - high rates of LC - about 1/4 with durable disease control 👉 supporting enrollment into EORTC OligoRare jamanetwork.com/journals/jamao…

Slide of day 1 of #GI25 . How to treat Esophageal /GEJ cancer in 2025 ? Spot on by Dr. Nina Niu Sanford Krishan Jethwa ASCO #GI25 LARVOL OncoAlert Oncology Brothers